BANSISONS TEA INDUSTRIES LTD.

Bansisons Tea Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Wednesday, July 1, 2026, and will remain in effect until 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026. The decision aligns with SEBI regulations concerning insider trading. Promoters, directors, KMPs, designated persons, connected persons, and their immediate relatives are prohibited from trading during this period. The company will announce the board meeting date for approving the financial results in due course.

Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) held its 39th Annual General Meeting (AGM) on June 25, 2026, via Video Conferencing. All resolutions presented, including the adoption of audited financial statements for the year ended March 31, 2026, the re-appointment of a director, and a scheme of capital reduction, were passed. The voting results, along with the Scrutinizer's Report dated June 26, 2026, have been filed. The meeting confirmed the successful passage of five resolutions.

Novyra Pharmachem Limited, formerly Bansisons Tea Industries Ltd, has filed its 39th Annual Report for the financial year 2025-2026. The report, in compliance with SEBI regulations, has been sent to shareholders and uploaded to the company's website. The filing also includes the notice for the 39th Annual General Meeting (AGM) scheduled for June 25, 2026, where audited financial statements and the re-appointment of a director will be considered.

Novyra Pharmachem Limited (formerly Bansisons Tea Industries Ltd) confirms no deviation or variation in the utilization of funds raised under preferential issue, as per Regulation 32 of SEBI guidelines. The report, filed for the quarter and year ended March 31, 2026, states that the ₹13,24,500 raised from 1,76,600 partly paid-up shares on June 9, 2025, was utilized as originally intended for working capital requirements. The Audit Committee and auditors have reviewed and found no deviations.

Bansisons Tea Industries Ltd has revised the details of its 39th Annual General Meeting (AGM) due to inadvertent errors in the earlier submission. The AGM will be held on Thursday, June 25, 2026, at 11:30 A.M. via VC/OAVM. The cut-off date for e-voting is Thursday, June 18, 2026, with the remote e-voting period from June 22 to June 24, 2026. Book closure dates are set from June 19 to June 25, 2026. The board meeting on May 26, 2026, approved the revised AGM notice.

Bansisons Tea Industries Ltd has revised the details of its 39th Annual General Meeting (AGM) due to inadvertent errors in the earlier submission. The AGM will be held on Thursday, June 25, 2026, at 11:30 A.M. via VC/OAVM. The cut-off date for e-voting is Thursday, June 18, 2026, with the remote e-voting period from Monday, June 22, 2026, to Wednesday, June 24, 2026. Book closure dates are set from June 19, 2026, to June 25, 2026. All other details from the previous outcome remain unchanged. The board meeting on May 26, 2026, commenced at 6:00 p.m. and concluded at 6:50 p.m.

Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) announced the Board of Directors approved a proposal for capital reduction under Sections 66 of the Companies Act, 2013, subject to BSE, shareholder, and statutory approvals. The board also approved the Director's Report and adopted the Secretarial Audit Report for the year ended March 31, 2026. The 39th Annual General Meeting (AGM) will be held on June 19, 2026, via video conferencing. The Register of Members & Share Transfer Books will be closed from June 13, 2026, to June 19, 2026, for the AGM. Mrs. Rupal Patel is appointed as Scrutinizer for remote e-voting and voting at the AGM.

Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve a reduction in capital. The meeting will also address fixing the date, time, and venue for the Annual General Meeting, closure of the Register of Members and Share Transfer Register, approving the draft notice for the AGM, appointing a scrutinizer for e-voting, and approving the Director's Report and Secretarial Audit Report for the year ended March 31, 2026.

Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) announced its audited financial results for the quarter and year ended March 31, 2026, along with the auditor's report. The Board of Directors approved the standalone audited financial results in a meeting held on May 02, 2026. M/s DGMS & Co. LLP, Chartered Accountants, issued an audit report with an unmodified opinion. The company's outstanding loans/revolving facilities from banks/financial institutions as of March 31, 2026, stood at ₹145.88 Lakh.

Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) announced audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone audited financial results at a meeting held on May 02, 2026. M/s DGMS & Co. LLP, Chartered Accountants, issued an audit report with an unmodified opinion. Total financial indebtedness of the listed entity including short-term and long-term debt is ₹145.88 Lakh.